Skip Navigation



Cardiovascular Research Advance Access [Accepted Manuscript] published online on January 30, 2009

Cardiovascular Research, doi:10.1093/cvr/cvp040
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
82/1/59    most recent
cvp040v2
cvp040v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Dhingra, S.
Right arrow Articles by Singal, P. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dhingra, S.
Right arrow Articles by Singal, P. K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org.

IL-10 attenuates TNF-{alpha}-induced NF{kappa}B pathway activation and cardiomyocyte apoptosis

Sanjiv Dhingra, Anita K. Sharma, Rakesh C. Arora, Jan Slezak* and Pawan K. Singal

Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Center and Department of Physiology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada

Address for correspondence: Dr. Pawan K. Singal Professor and Director Institute of Cardiovascular Sciences St. Boniface General Hospital Research Center 351 Tache Ave, Room R3022 Winnipeg, Manitoba, R2H 2A6, Canada Tel: 204-235-3887 Fax: 204-233-6723 Email: psingal{at}sbrc.ca

Aim: We have recently reported that tumor necrosis factor-{alpha} (TNF-{alpha}) increases oxidative stress and apoptosis in cardiomyocytes by upregulating p38 mitogen-activated protein (MAP) kinase phosphorylation. Interleukin-10 (IL-10) blocked these effects of TNF-{alpha} by upregulating extracellular signal-regulated kinase 1/2 (ERK1/2) MAP kinase phosphorylation. However, the precise site of this IL-10 action is still unknown, and this was investigated in the present study.

Methods and Results: Cardiomyocytes isolated from adult Sprague Dawley rats were exposed to TNF-{alpha} (10 ng/ml), IL-10 (10 ng/ml) and IL-10 + TNF-{alpha} (ratio 1) for 4 hrs. Hydrogen peroxide and antioxidant trolox were used as positive controls. Exposure to TNF-{alpha} resulted in an increase in the production of reactive oxygen species, the number of apoptotic cells, caspase-3 activation and poly-ADP ribose polymerase (PARP) cleavage. Increased oxidative stress by using hydrogen peroxide also caused apoptosis. The changes due to TNF-{alpha} were associated with an increase in inhibitor of {kappa}B kinase (IKK) and nuclear factor {kappa}B (NF{kappa}B) phosphorylation. IL-10 by itself had no effect, but it prevented the abovementioned TNF-{alpha}-induced changes. Trolox also mitigated TNF-{alpha} induced changes. Pre-exposure of cells to an IKK inhibitor (PS-1145) prevented TNF-{alpha}-induced caspase-3 and PARP cleavage. Inhibition of ERK 1/2 MAP kinase with PD98059 attenuated the protective role of IL-10 against TNF-{alpha}-induced activation of IKK and NF{kappa}B as well as cardiomyocyte apoptosis.

Conclusions: The present study shows that TNF-{alpha}-induced activation of the NF{kappa}B pathway plays a critical role in cardiomyocyte apoptosis. IL-10 prevents TNF{alpha}-induced NF{kappa}B activation and proapoptotic changes in cardiomyocytes by inhibiting IKK phosphorylation through the activation of ERK 1/2 MAP kinase.


Time for primary review: 24 Days

* Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovak Republic


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.